Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia
about
Microfabricated mammalian organ systems and their integration into models of whole animals and humansMulti-Organ toxicity demonstration in a functional human in vitro system composed of four organs.Supplementation with the extract of schisandrae fructus pulp, seed, or their combination influences the metabolism of lipids and glucose in mice fed with normal and hypercholesterolemic dietThe hepatocyte proteome in organotypic rat liver models and the influence of the local microenvironment.Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposureAllometric Scaling and Cell Ratios in Multi-Organ in vitro Models of Human Metabolism.In silico models for dynamic connected cell cultures mimicking hepatocyte-endothelial cell-adipocyte interaction circleMicroengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.Organs-on-a-chip: a new tool for drug discovery.Tissue chips - innovative tools for drug development and disease modeling.Microfluidic perfusion systems for secretion fingerprint analysis of pancreatic islets: applications, challenges and opportunities.Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk.Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.Microtechnology-based organ systems and whole-body models for drug screening.Organ-on-a-chip devices advance to market.On being the right size: scaling effects in designing a human-on-a-chip.Incubation under fluid dynamic conditions markedly improves the structural preservation in vitro of explanted skeletal muscles.Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.Organ-on-a-Chip Technology for Reproducing Multiorgan Physiology.Building an experimental model of the human body with non-physiological parameters.Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study.Systemic and vascular inflammation in an in-vitro model of central obesity.A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model.
P2860
Q27011459-82F371BE-7CA7-4170-977E-A3C251497C8EQ27300308-DBA0D336-EFE8-4FA8-9AD5-DE104C885BF2Q33614303-7F1EF2E6-3297-4E79-85FD-2789A46F2131Q33823338-27CE7EDD-16D3-4D90-A0ED-FF0445971E09Q34143269-C7EA89D3-4253-430D-A3BF-6FC9B7024B9DQ34722881-10F7308D-C7AE-4948-B1CF-0938E4E90E39Q35515758-C035101D-D6DA-4857-936D-3B2DEDA6C043Q35826421-1AB719AD-96E2-497B-B6ED-8111539CD3A8Q37630442-5BCFD470-CDFC-4B64-B60D-1E42ECDDD742Q38195304-B70B7FC8-24F3-464D-AD54-D73B4FD9D73AQ38644609-9C21EEC1-3741-46F9-ABCE-B521CF4116B9Q38687419-F4F19CCB-64A5-4AA1-ABB7-D26C7BF4F512Q38698979-E7D08C77-51F1-4FD2-9DCA-1B6FCABA322CQ38799238-048D22B4-EE9C-4E4B-A398-0940493F1E71Q38820083-8FA05BA8-3C15-458C-8B15-C5888767F77FQ39375469-B05BF960-79F8-46E5-A7FA-2117C299F3BDQ42442749-6F61A5A9-6D22-403B-B1DD-03E16A98DA19Q47094189-F444553A-40DC-4363-8AD0-CBCED376576BQ47283219-38ADA945-6F66-4302-AB8D-5E2CBCED5E98Q47442360-3ED7138C-5DE3-45F5-9CB5-CDEAB2275131Q47637355-F33E61CE-B280-4CDA-9464-D4F3EDE5DD05Q47917610-8CAFD90F-FD37-4E0B-92DE-B89301A94A5EQ48264487-F803A6AD-2A72-4FC8-982D-987C20CE025EQ50041778-60C4DC85-06DD-49FE-AA09-8C811A6B4942Q50590541-5CAC5BA3-6D50-4634-9230-74DCE9E1F3FC
P2860
Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@ast
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@en
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@nl
type
label
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@ast
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@en
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@nl
prefLabel
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@ast
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@en
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@nl
P2093
P2860
P1433
P1476
Glucose and fatty acid metabol ...... with normo- and hyperglycaemia
@en
P2093
Angelo Avogaro
Bruna Vinci
Elisabetta Iori
Ellen Murphy
Maria Cristina Marescotti
P2860
P304
P356
10.1371/JOURNAL.PONE.0034704
P407
P577
2012-04-11T00:00:00Z